(4bR,8aS)-4b-(5-Amino-1,3,4-oxadiazol-2-yl)-2-isopropyl-8,8-dimethyl-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-3,4-diol

ID: ALA4447309

Chembl Id: CHEMBL4447309

PubChem CID: 155518943

Max Phase: Preclinical

Molecular Formula: C21H29N3O3

Molecular Weight: 371.48

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)c1cc2c(c(O)c1O)[C@@]1(c3nnc(N)o3)CCCC(C)(C)[C@@H]1CC2

Standard InChI:  InChI=1S/C21H29N3O3/c1-11(2)13-10-12-6-7-14-20(3,4)8-5-9-21(14,15(12)17(26)16(13)25)18-23-24-19(22)27-18/h10-11,14,25-26H,5-9H2,1-4H3,(H2,22,24)/t14-,21+/m0/s1

Standard InChI Key:  OBTWNXPOBRZQLS-LHSJRXKWSA-N

Alternative Forms

  1. Parent:

    ALA4447309

    ---

Associated Targets(Human)

FDPS Tclin Farnesyl diphosphate synthase (1240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GGPS1 Tchem Geranylgeranyl pyrophosphate synthetase (715 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PANC-1 (6144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 371.48Molecular Weight (Monoisotopic): 371.2209AlogP: 4.25#Rotatable Bonds: 2
Polar Surface Area: 105.40Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 9.72CX Basic pKa: CX LogP: 4.30CX LogD: 4.30
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.68Np Likeness Score: 1.49

References

1. Han S, Li X, Xia Y, Yu Z, Cai N, Malwal SR, Han X, Oldfield E, Zhang Y..  (2019)  Farnesyl Pyrophosphate Synthase as a Target for Drug Development: Discovery of Natural-Product-Derived Inhibitors and Their Activity in Pancreatic Cancer Cells.,  62  (23): [PMID:31725297] [10.1021/acs.jmedchem.9b01405]

Source